StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > GUIDANCE NEEDED

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 20, 2021 7:06pm

80 Views

Post# 32620014

RE:RE:RE:RE:RE:GUIDANCE NEEDED

Or was it verified? Lol

Jonnyboy85 wrote: Pardom me, Lith*
Jonnyboy85 wrote: Also , for the record Lith I didn't say a word to you until you posted this. So who's the one causing all the storms here Nails?
LithLover wrote: Give it a rest Jonny. We have the right to hold the CEO's feet to the fire. We have been here over 5 years and supported and held. He had a false start with colonsentry this needs to be done right. The silence for 2 months is not the right approach given the importance of this commercialization.

MarketMoney wrote:

capebretongirl wrote: Its just been too long since a last meaningul NR - this company can't just sit back and let the chips fall where they may - this is their chance to market it and propel momentum on a breakthrough stock. Even an update at this point confirming the number of covid tests being conducted, how that revenue will be used for Aristotle etc. would go a long way in promoting some interest. As it now stands we talk every Friday about a Monday a.m. bulletin but it just never happens. I am long here and patient but common sense tells me there is a better way to do things.

I must say I agree with you, lack of communication that's for sure. I think the fact that CEO does more public presentation to get new investor join them but leaves the old investor hanging with thirst of news of development.